- Home
- Companies
- north america
- stem cell
Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Air and Climate
- Agriculture
- Environmental
- Health and Safety
- University / Academia / Research
- Government
- Manufacturing, Other
- Food and Beverage
- Water and Wastewater
- Soil and Groundwater
- Energy
- Aerospace & Air Transport
- Waste and Recycling
- Oil, Gas & Refineries
- Defense
- Paint
- Plastics & Resins
- Construction & Construction Materials
- Mining
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Glassware
- Retail
- Commercial
- Metal
- Printing
Stem Cell Suppliers In North America
181 companies found
based inAnn Arbor, MICHIGAN (USA)
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by ...
Built on more than 45 years of BD experience and leadership in flow cytometry and multicolor analysis, the BD FACSCanto™ II Flow Cytometry Systems deliver reliable performance, accuracy and ease-of-use for today's busy clinical ...
based inHouston, TEXAS (USA)
cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria ...
Mitochondria dysfunction has been tied to a host of medical conditions, including heart disease, stroke, diabetes, Parkinson's and Alzheimer's. But mitochondria have, for the most part, eluded treatment. This compelled Dr. McCully and his team to ...
based inBasel, SWITZERLAND
At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of 15,000 skilled employees work across a global network of more than 30 sites to deliver for our customers across the ...
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 SingleQuotsTM Supplements (CC-4176) required for growth of Endothelial Cells. Available for immediate ...
based inMountain View, CALIFORNIA (USA)
Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to ...
CBM588 is an orally-administered Clostridium butyricum strain with a long history of clinical use and safety in all age groups in Japan. In Japan, CBM588 has primarily been used to treat infectious and noninfectious diarrheal disorders associated ...
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
LAD-I is a rare genetic disorder affecting the immune system and is caused by a defect in the ITGB2 gene, leading to a deficiency in CD18. Due to this deficiency, white blood cells (primarily neutrophils) are unable to leave the bloodstream to go to ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
CardioPRIME® is the AnaBios approach for measuring human cardiomyocyte functionality and sets the industry standard for cardiac-based biomedical research. By leveraging the robust excitation-contraction coupling of mature primary human ...
based inIndianapolis, INDIANA (USA)
One of the largest inhibitors to the advancement of translational research is a lack of specific reagents, antibodies, analytes, and support services for those scientists involved in the early stages of research and development using animal models. ...
Regenerative medicine is a discipline of medicine that focuses on the repair or replacement of damaged or diseased cells or tissues. Many institutions are developing novel methods to use naturally occurring cells, transgenic cells, ...
based inFreiburg, GERMANY
CYTENA, the premier provider of single-cell dispensers, liquid handlers and live cell analyzers, started out in 2014 as a spin-off from the Laboratory for MEMS Applications and the Hahn-Schickard Institute in Freiburg, Germany. In 2019, CYTENA ...
Faster than Ever Before: By automating labor-intensive and time-consuming steps, the F.SIGHT 2.0 significantly streamlines Cell Line Development (CLD), Cell & Gene therapy, as well as Single-cell Omics workflows. The F.SIGHT 2.0 is the fastest ...
based inSalt Lake City, UTAH (USA)
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics’ cell isolation ...
DiscGenics uses its patented allogeneic cell culture manufacturing technology to isolate cells from donated adult human intervertebral disc tissue and induce a progenitor state. These proprietary Discogenic Cells are then expanded for therapeutic ...
based inAmes, ILLINOIS (USA)
BioForce Nanosciences, Inc. develops and commercializes nanotech instruments, consumables, and applications for the life sciences. The company has been providing consumable support products for atomic force microscopy (AFM) for over a decade. In ...
based inSan Diego, CALIFORNIA (USA)
BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality ...
based inSan Jose, CALIFORNIA (USA)
We provide our customers with innovative bioanalytical solutions for protein and cell biology in life science research, pharmaceutical and biotherapeutic development. With over 140,000 placements in laboratories around the world, our instruments ...
Organoids are derived from biopsies and tissues sampled from patients or subjects (usually termed Patient-Derived Organoids, or PDOs). PDOs are self-organising cell structures that mimic the tissue or organ from which they are derived – they ...
based inHolliston, MASSACHUSETTS (USA)
HRGN is a clinical-stage biotechnology company that uses a patient’s own stem cells that are grown on a hollow tubular scaffold to regenerate organ tissue damaged from cancer, trauma, birth defects or other diseases. The patient’s stem ...
Following extensive research and development, Biostage has evolved its technology to optimize the interaction of mesenchymal stem cells seeded on a biocompatible scaffold. Preclinical studies suggest that, once ...
based inSyracuse, NEW YORK (USA)
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet technology is a ...
ZetaFuse is driven by the activation of a novel molecular pathway, by leveraging this patented mechanism, to directly turn stem cells into osteoblasts (osteoinductive) and prevents bone resorption ...
based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Pursuing an Unmet Need in the Treatment of AML - SENTI-202 is designed to target and eliminate acute myeloid leukemia cells while sparing healthy bone marrow. Our vision is a potential medicine that does not rely on an invasive bone marrow ...
based inCambridge, MASSACHUSETTS (USA)
Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around ...
EDIT-301 is an experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). EDIT-301 consists of patient-derived ...
based inMinneapolis, MINNESOTA (USA)
Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science ...
based inIrvine, CALIFORNIA (USA)
Biogennix is a leading developer of advanced osteobiologic products specifically designed for orthopedic and spine surgery. Founded in 2009, we are led by a team of scientists and industry veterans committed to delivering innovative products for ...
One of the primary functions of a bone graft material is to provide an osteoconductive surface for new bone formation. Bone regeneration is a cellular process that involves the interaction of osteoblasts and stem ...
based inSan Diego, CALIFORNIA (USA)
Rady Children’s Institute for Genomic Medicine is a non-profit research organization embedded within Rady Children’s Hospital-San Diego. We pioneered a medical revolution to end the diagnostic odyssey for neonatal and pediatric rare disease. Now ...
based inNew York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
INB-100, our DeltEx Allo, is an allogeneic product candidate, initially developed for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation (HSCT). This is the first ...
